trastornos endocrinológicos y metabólicos
Porfirias agudas
Referencias del tratamiento
1.Bonkovsky HL, Healey JF, Lourie AN, and Gerron GG: Intravenous heme-albumin in acute intermittent porphyria. Evidence for repletion of hepatic hemoproteins and regulatory heme pools.Am J Gastroenterol86: 1050–1056, 1991. 2.Balwani M, Sardh E, Ventura P, et al: Phase 3 trial of RNAi therapeuticgivosiranfor acute intermittent porphyria.N Engl J Med382: 2289–2301, 2020. 3.Sardh E, Harper P, Balwani M, et al: Phase 1 trial of an RNA interference therapy for acute intermittent porphyria.N Engl J Med380: 549–558, 2019. 4.Majeed CN, Ma CD, Xiao T, et al: Spotlight ongivosiranas a treatment Option for adults with acute hepatic porphyria: Design, development, and place in therapy.Drug Des Devel Ther16:1827–1845, 2022. doi:10.2147/DDDT.S281631 5.Ventura P, Bonkovsky HL, Gouya L, et al: Efficacy and safety ofgivosiranfor acute hepatic porphyria: 24-month interim analysis of the randomized phase 3 ENVISION study.Liver Int42(1):161–172, 2022. doi:10.1111/liv.15090 6.Dowman JK, Gunson BK, Mirza DF, et al: Liver transplant for acute intermittent porphyria is complicated by a high rate of hepatic artery thrombosis.Liver Transpl18: 195–200, 2012. doi: 10.1002/lt.22345 7.Lissing M, Nowak G, Adam R, et al: Liver transplantation for acute intermittent porphyria.Liver Transpl27(4):491–501, 2021. doi:10.1002/lt.25959 8. Wahlin S, Harper P, Sardh E, et al: Combined liver and kidney transplantation in acute intermittent porphyria.Transpl Int23(6):e18–e21, 2010. doi:10.1111/j.1432-2277.2009.01035.x 9.Thunell S, Henrichson A, Floderus Y, et al: Liver transplantation in a boy with acute porphyria due to aminolaevulinate dehydratase deficiency.Eur J Clin Chem Clin Biochem30: 599–606, 1992. 